Is day-to-day discrepancy in Bravo pH monitoring related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease?
Patients with a discrepancy between days of Bravo pH monitoring have lower esophageal acid exposure. Variability between the 2 days represents early deterioration of the gastroesophageal barrier and indicates less advanced reflux disease.
The data suggest that adiponectin is a significant metabolic concomitant of HTGL activity in African Americans.